抗CTLA-4抗体に関連する免疫関連有害事象：系統的レビューとメタ解析

Bertrandら（木曜日）はこの問題を研究した。

www.synapsesocial.com/papers/69d6bfdbfca0359822aa8312 — DOI: https://doi.org/10.1186/s12916-015-0455-8

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Has the Microbiota Played a Critical Role in the Evolution of the Adaptive Immune System?· 2010 · 1,126 citations
2. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4· 1995 · 2,889 citations
3. The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network· 2013 · 470 citations
4. Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival· 2013 · 308 citations
5. Immune Toxicities and Long Remission Duration after Ipilimumab Therapy for Metastatic Melanoma: Two Illustrative Cases· 2013 · 40 citations